Author

David J. Tester

Mayo ClinicORCID 0000-0003-4554-2244Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:ChIP-seq· 1 Research Focus:database / resource· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Michael John AckermaniD· 3 shared Cristobal G. dos RemediosiD· 2 shared Evelyn T. Kim· 2 shared Johan Martijn BosiD· 2 shared John R. GiudicessiiD· 2 shared Joseph A. DearaniiD· 2 shared Joseph John MaleszewskiiD· 2 shared Ramin GarmanyiD· 2 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioinformatics

Michael John AckermanORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioinformaticsJournal of Molecular and Cellular CardiologyPeer-reviewedSep 8, 2024

A Multi-Omics Atlas of Sex-Specific Differences in Obstructive Hypertrophic Cardiomyopathy

Ramin Garmany, Surendra Dasari, Johan Martijn Bos…·Michael John Ackerman

This study identifies sex-specific differences in multi-omics profiles of obstructive hypertrophic cardiomyopathy patients compared to controls.

11 citations

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintMay 9, 2024

Histone Modifications and miRNA Perturbations Contribute to Transcriptional Dysregulation of Hypertrophy in Obstructive Hypertrophic Cardiomyopathy

Ramin Garmany, Surendra Dasari, Johan Martijn Bos…·Michael John Ackerman

The paper identifies miRNA and histone modifications as contributors to transcriptional downregulation of hypertrophy pathways in obstructive hypertrophic cardiomyopathy.

1 citation

𝕏 PostBluesky

GeneticsbioRxivPreprintAug 5, 2019

SORBS2 is a susceptibility gene to arrhythmogenic right ventricular cardiomyopathy

Yonghe Ding, Jingchun Yang, Peng Chen…·Xiaolei Xu

The paper identifies SORBS2 as a new susceptibility gene for arrhythmogenic right ventricular cardiomyopathy (ARVC) using zebrafish and mouse models and human patient sequencing.

2 citations

𝕏 PostBluesky